IP that matters: behind Orexo’s patent win against generic giant (NLS Days)

IP that matters: behind Orexo’s patent win against generic giant (NLS Days)
date
October 13, 2025
TIme
16:30 - 17:30 CEST
Address

Flow Stage, Svenska Mässan, Gothenburg

When a challenger comes for your life’s work, how do you fight back and win?

At Nordic Life Science Days, you’ll get a rare inside look at Orexo’s decisive US patent litigation victory over Sun Pharma, a case that proves the power of a rock-solid IP strategy in protecting both innovation and patient impact. 

Hear from those who lived it: 

  • Orexo – on the effective use of IP to meet its business objectives, safeguarding lifechanging treatments for opioid dependence; 
  • Steptoe -  US litigators who brought and successfully argued the case before the court; and
  • Potter Clarkson – Orexo’s patent attorneys who had a key, central role in preparing the ground for that success

Join us on the Flow Stage at 16:30, Monday 13 October for an insightful session.

Because when innovation is under fire, strategy is everything. 

Latest News

How can patents and designs maximise the value of a fashion business?

How can patents and designs maximise the value of a fashion business?

The UK cyber security market in 2026: growth, investment and the road to 2031

The UK cyber security market in 2026: growth, investment and the road to 2031

How can trade marks maximise the value of a fashion brand?

How can trade marks maximise the value of a fashion brand?

How to prepare your IP for debt finance lending

How to prepare your IP for debt finance lending

Can you use IP as collateral to secure debt financing as your business develops?

Can you use IP as collateral to secure debt financing as your business develops?

Branding in sportstech: why brand is now a strategic advantage

Branding in sportstech: why brand is now a strategic advantage

How can trade secrets maximise the value of a fashion business?

How can trade secrets maximise the value of a fashion business?

AI cyber security strategy in 2026: innovation, risk, and IP

AI cyber security strategy in 2026: innovation, risk, and IP

See All News